Weekly versus monthly testosterone administration on fast and slow skeletal muscle fibers in older adult males

Robert H. Fitts, James R. Peters, Edgar Dillon, William J. Durham, Melinda Sheffield-Moore, Randall Urban

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Context: In older adults, loss of mobility due to sarcopenia is exacerbated in men with low serum T. T replacement therapy is known to increase muscle mass and strength, but the effect of weekly (WK) vs monthly (MO) administration on specific fiber types is unknown. Objective: To determine the efficacy of WKvs MOT replacement on the size and functional capacity of individual fast and slow skeletal muscle fiber types. Design, Setting, and Patients: Subjects were randomized into a 5-month, double-blind, placebo-controlled trial. All subjects (ages, 61-71 y) were community-dwelling men who hadT levels < 500 ng/dL Intervention: Subjects were dosed weekly for 5 months, receiving continuous T(WK, n = 5; 100 mg T enanthate, im injection), monthly cycled T (MO, n = 7; alternating months of Tand placebo), or placebo (n = 7). Muscle biopsies of the vastus lateralis were obtained before and after treatment. Main Outcome Measures: Main outcomes for individual slow and fast fibers included fiber diameter, peak force (P<inf>0</inf>), rate of tension development, maximal shortening velocity, peak power, and Ca<sup>2+</sup> sensitivity. Results: Both treatments increased fiber diameter and peak power, with WK treatment 5-fold more effective than MO in increasing type I fiber P<inf>0</inf>. WK effects on fiber diameter and force were 1.5-fold higher in slow fibers compared to fast fibers. In fasttype II fibers, diameter and P<inf>0</inf> increased similarly between treatments. The increased power was entirely due to increased fiber size and force. Conclusions: In conclusion, T replacement effects were fiber-type dependent, restricted to increases in cell size, P<inf>0</inf>, and peak power, and dependent on the paradigm selected (WKvs MO).

Original languageEnglish (US)
Pages (from-to)E223-E231
JournalJournal of Clinical Endocrinology and Metabolism
Volume100
Issue number2
DOIs
StatePublished - Feb 1 2015

Fingerprint

Skeletal Muscle Fibers
Muscle
Testosterone
Fibers
Sarcopenia
Independent Living
Muscle Strength
Therapeutics
Cell Size
Placebos
Serum

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Weekly versus monthly testosterone administration on fast and slow skeletal muscle fibers in older adult males. / Fitts, Robert H.; Peters, James R.; Dillon, Edgar; Durham, William J.; Sheffield-Moore, Melinda; Urban, Randall.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 100, No. 2, 01.02.2015, p. E223-E231.

Research output: Contribution to journalArticle

Fitts, Robert H. ; Peters, James R. ; Dillon, Edgar ; Durham, William J. ; Sheffield-Moore, Melinda ; Urban, Randall. / Weekly versus monthly testosterone administration on fast and slow skeletal muscle fibers in older adult males. In: Journal of Clinical Endocrinology and Metabolism. 2015 ; Vol. 100, No. 2. pp. E223-E231.
@article{f71136b3a72d46b49d115dcb5bb8d508,
title = "Weekly versus monthly testosterone administration on fast and slow skeletal muscle fibers in older adult males",
abstract = "Context: In older adults, loss of mobility due to sarcopenia is exacerbated in men with low serum T. T replacement therapy is known to increase muscle mass and strength, but the effect of weekly (WK) vs monthly (MO) administration on specific fiber types is unknown. Objective: To determine the efficacy of WKvs MOT replacement on the size and functional capacity of individual fast and slow skeletal muscle fiber types. Design, Setting, and Patients: Subjects were randomized into a 5-month, double-blind, placebo-controlled trial. All subjects (ages, 61-71 y) were community-dwelling men who hadT levels < 500 ng/dL Intervention: Subjects were dosed weekly for 5 months, receiving continuous T(WK, n = 5; 100 mg T enanthate, im injection), monthly cycled T (MO, n = 7; alternating months of Tand placebo), or placebo (n = 7). Muscle biopsies of the vastus lateralis were obtained before and after treatment. Main Outcome Measures: Main outcomes for individual slow and fast fibers included fiber diameter, peak force (P0), rate of tension development, maximal shortening velocity, peak power, and Ca2+ sensitivity. Results: Both treatments increased fiber diameter and peak power, with WK treatment 5-fold more effective than MO in increasing type I fiber P0. WK effects on fiber diameter and force were 1.5-fold higher in slow fibers compared to fast fibers. In fasttype II fibers, diameter and P0 increased similarly between treatments. The increased power was entirely due to increased fiber size and force. Conclusions: In conclusion, T replacement effects were fiber-type dependent, restricted to increases in cell size, P0, and peak power, and dependent on the paradigm selected (WKvs MO).",
author = "Fitts, {Robert H.} and Peters, {James R.} and Edgar Dillon and Durham, {William J.} and Melinda Sheffield-Moore and Randall Urban",
year = "2015",
month = "2",
day = "1",
doi = "10.1210/jc.2014-2759",
language = "English (US)",
volume = "100",
pages = "E223--E231",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "2",

}

TY - JOUR

T1 - Weekly versus monthly testosterone administration on fast and slow skeletal muscle fibers in older adult males

AU - Fitts, Robert H.

AU - Peters, James R.

AU - Dillon, Edgar

AU - Durham, William J.

AU - Sheffield-Moore, Melinda

AU - Urban, Randall

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Context: In older adults, loss of mobility due to sarcopenia is exacerbated in men with low serum T. T replacement therapy is known to increase muscle mass and strength, but the effect of weekly (WK) vs monthly (MO) administration on specific fiber types is unknown. Objective: To determine the efficacy of WKvs MOT replacement on the size and functional capacity of individual fast and slow skeletal muscle fiber types. Design, Setting, and Patients: Subjects were randomized into a 5-month, double-blind, placebo-controlled trial. All subjects (ages, 61-71 y) were community-dwelling men who hadT levels < 500 ng/dL Intervention: Subjects were dosed weekly for 5 months, receiving continuous T(WK, n = 5; 100 mg T enanthate, im injection), monthly cycled T (MO, n = 7; alternating months of Tand placebo), or placebo (n = 7). Muscle biopsies of the vastus lateralis were obtained before and after treatment. Main Outcome Measures: Main outcomes for individual slow and fast fibers included fiber diameter, peak force (P0), rate of tension development, maximal shortening velocity, peak power, and Ca2+ sensitivity. Results: Both treatments increased fiber diameter and peak power, with WK treatment 5-fold more effective than MO in increasing type I fiber P0. WK effects on fiber diameter and force were 1.5-fold higher in slow fibers compared to fast fibers. In fasttype II fibers, diameter and P0 increased similarly between treatments. The increased power was entirely due to increased fiber size and force. Conclusions: In conclusion, T replacement effects were fiber-type dependent, restricted to increases in cell size, P0, and peak power, and dependent on the paradigm selected (WKvs MO).

AB - Context: In older adults, loss of mobility due to sarcopenia is exacerbated in men with low serum T. T replacement therapy is known to increase muscle mass and strength, but the effect of weekly (WK) vs monthly (MO) administration on specific fiber types is unknown. Objective: To determine the efficacy of WKvs MOT replacement on the size and functional capacity of individual fast and slow skeletal muscle fiber types. Design, Setting, and Patients: Subjects were randomized into a 5-month, double-blind, placebo-controlled trial. All subjects (ages, 61-71 y) were community-dwelling men who hadT levels < 500 ng/dL Intervention: Subjects were dosed weekly for 5 months, receiving continuous T(WK, n = 5; 100 mg T enanthate, im injection), monthly cycled T (MO, n = 7; alternating months of Tand placebo), or placebo (n = 7). Muscle biopsies of the vastus lateralis were obtained before and after treatment. Main Outcome Measures: Main outcomes for individual slow and fast fibers included fiber diameter, peak force (P0), rate of tension development, maximal shortening velocity, peak power, and Ca2+ sensitivity. Results: Both treatments increased fiber diameter and peak power, with WK treatment 5-fold more effective than MO in increasing type I fiber P0. WK effects on fiber diameter and force were 1.5-fold higher in slow fibers compared to fast fibers. In fasttype II fibers, diameter and P0 increased similarly between treatments. The increased power was entirely due to increased fiber size and force. Conclusions: In conclusion, T replacement effects were fiber-type dependent, restricted to increases in cell size, P0, and peak power, and dependent on the paradigm selected (WKvs MO).

UR - http://www.scopus.com/inward/record.url?scp=84928327082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928327082&partnerID=8YFLogxK

U2 - 10.1210/jc.2014-2759

DO - 10.1210/jc.2014-2759

M3 - Article

VL - 100

SP - E223-E231

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 2

ER -